Biotechnology Study In India
- All
- News
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
- Thursday December 23, 2021
- India News | Press Trust of India
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
www.ndtv.com
-
Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study
- Tuesday February 9, 2021
- World News | Press Trust of India
The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
-
www.ndtv.com
-
Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study
- Thursday December 31, 2020
- World News | Press Trust of India
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.
-
www.ndtv.com
-
How Ginger Is More Effective Than Chemotherapy In Treating Cancer
- Thursday April 26, 2018
- DoctorNDTV
A recent study conducted by the Rajiv Gandhi Centre for Biotechnology in India stated ginger a powerful remedy for treating cancer, certainly more powerful than chemotherapy.
-
doctor.ndtv.com
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
- Thursday December 23, 2021
- India News | Press Trust of India
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
www.ndtv.com
-
Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study
- Tuesday February 9, 2021
- World News | Press Trust of India
The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
-
www.ndtv.com
-
Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study
- Thursday December 31, 2020
- World News | Press Trust of India
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.
-
www.ndtv.com
-
How Ginger Is More Effective Than Chemotherapy In Treating Cancer
- Thursday April 26, 2018
- DoctorNDTV
A recent study conducted by the Rajiv Gandhi Centre for Biotechnology in India stated ginger a powerful remedy for treating cancer, certainly more powerful than chemotherapy.
-
doctor.ndtv.com